Atlas Trials

Prevalence of Strokes Secondary to a Reversible Cerebral Vasoconstriction Attributable to Cannabis Consumption in Young Subjects (≤ 45 Years) Hospitalized for an Ischaemic Stroke

Clinical trial NCT03379857 · UNKNOWN

Trial details

NCT number
NCT03379857
Sponsor
University Hospital, Strasbourg, France
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
StrokeCannabis Use
Start date
2018-01-11
Primary completion
2025-01-11
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.